528 related articles for article (PubMed ID: 29250800)
1. Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations.
Lightner AL; McKenna NP; Tse CS; Raffals LE; Loftus EV; Mathis KL
Aliment Pharmacol Ther; 2018 Mar; 47(5):573-580. PubMed ID: 29250800
[TBL] [Abstract][Full Text] [Related]
2. Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease.
Lightner AL; Raffals LE; Mathis KL; Cima RR; Tse CS; Pemberton JH; Dozois EJ; Loftus EV
J Crohns Colitis; 2017 Feb; 11(2):185-190. PubMed ID: 27543504
[TBL] [Abstract][Full Text] [Related]
3. Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study.
Lightner AL; Mathis KL; Tse CS; Pemberton JH; Shen B; Kochhar G; Singh A; Dulai PS; Eisenstein S; Sandborn WJ; Parry L; Stringfield S; Hudesman D; Remzi F; Loftus EV
Inflamm Bowel Dis; 2018 Mar; 24(4):871-876. PubMed ID: 29509927
[TBL] [Abstract][Full Text] [Related]
4. Postoperative outcomes in vedolizumab-treated pediatric patients undergoing abdominal operations for inflammatory bowel disease.
Lightner AL; Tse CS; Potter DD; Moir C
J Pediatr Surg; 2018 Sep; 53(9):1706-1709. PubMed ID: 29111083
[TBL] [Abstract][Full Text] [Related]
5. Hypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn's Disease Patients Undergoing Ileocolic Resection.
Shah RS; Bachour S; Jia X; Holubar SD; Hull TL; Achkar JP; Philpott J; Qazi T; Rieder F; Cohen BL; Regueiro MD; Lightner AL; Click BH
J Crohns Colitis; 2021 Jul; 15(7):1142-1151. PubMed ID: 33388775
[TBL] [Abstract][Full Text] [Related]
6. Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients.
Lightner AL; McKenna NP; Alsughayer A; Loftus EV; Raffals LE; Faubion WA; Moir C
J Pediatr Surg; 2019 Oct; 54(10):2162-2165. PubMed ID: 30773391
[TBL] [Abstract][Full Text] [Related]
7. Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.
Lightner AL; McKenna NP; Moncrief S; Pemberton JH; Raffals LE; Mathis KL
Inflamm Bowel Dis; 2017 Dec; 23(12):2197-2201. PubMed ID: 28858072
[TBL] [Abstract][Full Text] [Related]
8. Systematic Review and Meta-Analysis: Preoperative Vedolizumab and Postoperative Complications in Patients with IBD.
Moosvi Z; Duong JT; Bechtold ML; Nguyen DL
South Med J; 2021 Feb; 114(2):98-105. PubMed ID: 33537791
[TBL] [Abstract][Full Text] [Related]
9. Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab.
Yamada A; Komaki Y; Patel N; Komaki F; Aelvoet AS; Tran AL; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
Am J Gastroenterol; 2017 Sep; 112(9):1423-1429. PubMed ID: 28719595
[TBL] [Abstract][Full Text] [Related]
10. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
Yamada A; Komaki Y; Patel N; Komaki F; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
Inflamm Bowel Dis; 2018 Feb; 24(3):502-509. PubMed ID: 29462385
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
Syed A; Cross RK; Flasar MH
Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144
[TBL] [Abstract][Full Text] [Related]
12. The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis.
Rosenfeld G; Qian H; Bressler B
J Crohns Colitis; 2013 Dec; 7(11):868-77. PubMed ID: 23466411
[TBL] [Abstract][Full Text] [Related]
13. Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients.
Chapuis-Biron C; Bourrier A; Nachury M; Nancey S; Bouhnik Y; Serrero M; Armengol-Debeir L; Buisson A; Tran-Minh ML; Zallot C; Fumery M; Bouguen G; Abitbol V; Viennot S; Chanteloup E; Rajca S; Dib N; Parmentier AL; Peyrin-Biroulet L; Vuitton L;
Aliment Pharmacol Ther; 2020 Apr; 51(7):719-727. PubMed ID: 32080886
[TBL] [Abstract][Full Text] [Related]
14. Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease.
El-Hussuna A; Andersen J; Bisgaard T; Jess P; Henriksen M; Oehlenschlager J; Thorlacius-Ussing O; Olaison G
Scand J Gastroenterol; 2012 Jun; 47(6):662-8. PubMed ID: 22486168
[TBL] [Abstract][Full Text] [Related]
15. Vedolizumab as induction and maintenance therapy for Crohn's disease.
Sandborn WJ; Feagan BG; Rutgeerts P; Hanauer S; Colombel JF; Sands BE; Lukas M; Fedorak RN; Lee S; Bressler B; Fox I; Rosario M; Sankoh S; Xu J; Stephens K; Milch C; Parikh A;
N Engl J Med; 2013 Aug; 369(8):711-21. PubMed ID: 23964933
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes of patients treated with ustekinumab vs. vedolizumab in inflammatory bowel disease: a matched case analysis.
Novello M; Stocchi L; Holubar S; Shawki S; Lipman J; Gorgun E; Hull T; Steele SR
Int J Colorectal Dis; 2019 Mar; 34(3):451-457. PubMed ID: 30535559
[TBL] [Abstract][Full Text] [Related]
17. Postoperative Safety Profile of Minimally Invasive Ileocolonic Resections for Crohn's Disease in the Era of Biologic Therapy.
Abd El Aziz MA; Abdalla S; Calini G; Saeed H; Stocchi L; Merchea A; Colibaseanu DT; Shawki S; Larson DW
J Crohns Colitis; 2022 Aug; 16(7):1079-1088. PubMed ID: 35045164
[TBL] [Abstract][Full Text] [Related]
18. Abdominal surgery in the older Crohn's population.
Norris B; Solomon MJ; Eyers AA; West RH; Glenn DC; Morgan BP
Aust N Z J Surg; 1999 Mar; 69(3):199-204. PubMed ID: 10075359
[TBL] [Abstract][Full Text] [Related]
19. Postoperative complications of pediatric patients with inflammatory bowel disease treated with vedolizumab.
Zimmerman LA; Zalieckas JM; Shamberger RC; Bousvaros A
J Pediatr Surg; 2018 Jul; 53(7):1330-1333. PubMed ID: 29370898
[TBL] [Abstract][Full Text] [Related]
20. Case-matched Comparison of Postoperative Outcomes Following Surgery for Inflammatory Bowel Disease After Exposure to Vedolizumab vs Other Biologics.
Novello M; Stocchi L; Steele SR; Holubar SD; Duraes LC; Kessler H; Shawki S; Hull LT
J Crohns Colitis; 2020 Feb; 14(2):185-191. PubMed ID: 31328222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]